- Infection prevention product manufacturer Tristel said it expected to post a rise in adjusted annual profit of at least 17%.

Pre-tax profit, before share-based payments to executives, for the year through June was seen rising to at least £5.5m, up from £4.7m on-year.

Revenue was expected to rise to £26m, up from £22.2m, with revenue from overseas markets climbing 26% and contributing 55% of total revenues.

Revenue in the UK rose by 9%.

Tristel also announced that it had acquired the remaining 80% of Tristel Italia from Michael Donaldson that it didn't already own, for €661k.

An additional cash consideration of €150k may be paid over the next two years if sales reached €926k in the year ending 30 June 2021.

'We are very pleased with the performance of the company during the year,' chief executive Paul Swinney said.

'The balance of our business continues not only to shift towards our higher growth overseas markets, but also towards our higher margin chlorine dioxide technology.'

Story provided by